Insider sale notice lists recent disposals by PRVA (PRVA) reporting person

Rhea-AI Filing Summary

PRVA filing notifies proposed dispositions of common stock under Rule 144 and lists recent completed sales by a reporting person. The excerpt shows four reported sales by David Mountcastle: 23,887 shares on 12/12/2025, 5,361 on 02/26/2026, 7,697 on 02/27/2026, and 5,177 on 03/06/2026. It also lists 5,829 common shares tied to restricted stock vesting on 03/06/2026.

Insights

Corporate Governance Analyst

Routine Rule 144 notice showing multiple recent dispositions by a reporting person.

The filing documents proposed and recent sales of common stock by a reporting person, including specific share counts and dates. The entries include a restricted stock vesting of 5,829 shares on 03/06/2026, which appears linked to compensation.

Transaction timing and exact cash proceeds are not provided in the excerpt; subsequent filings or broker reports would show execution details.

Securities Compliance Specialist

Form 144 disclosure aligns with standard resale notice requirements; no regulatory outcome shown.

The notice lists the method as restricted stock vesting and identifies the broker on NASDAQ-related activity. The filing names the reporting person and provides per-trade share counts and dates, consistent with Rule 144 reporting practice.

Impact on ownership or dilution is not quantified in this excerpt; further filings would be needed to assess total beneficial ownership.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5829	133158.26	123688289	03/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2026	Restricted Stock Vesting	Issuer			5829	03/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd., Suite 700 Arlington VA 22203	Common	12/12/2025	23887	597793.14
David Mountcastle 950 N. Glebe Rd., Suite 700 Arlington VA 22203	Comomn	02/26/2026	5361	134030.87
David Mountcastle 950 N. Glebe Rd., Suite 700 Arlington VA 22203	Common	02/27/2026	7697	192798.08
David Mountcastle 950 N. Glebe Rd., Suite 700 Arlington VA 22203	Common	03/06/2026	5177	119852.73

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PRVA's Form 144 show about recent insider sales?

Answer: The Form 144 lists four reported sales by David Mountcastle totaling 42,122 shares across December 2025 and February–March 2026. It provides share counts and trade dates but does not state cash proceeds or prices in the excerpt.

Does the filing include any vested restricted stock for PRVA?

Answer: Yes, the excerpt shows 5,829 common shares tied to restricted stock vesting on 03/06/2026 listed under 'Securities To Be Sold' with the purpose coded as Compensation.

Who is the reporting person named in the PRVA Form 144?

Answer: The filing names David Mountcastle and lists his address. Multiple sales by Mr. Mountcastle are recorded with specific dates and share amounts in the provided excerpt.

Does the Form 144 excerpt show proceeds or sale prices for PRVA transactions?

Answer: The excerpt includes numeric values adjacent to the trades but does not clearly label proceeds or per-share prices; the filing provides share counts and dates, not explicit proceeds treatment in this excerpt.